SANTEN PHARMACEUTICAL CO.,LTD.JP:4536

Market cap
¥636.6B
P/E ratio
34.1x
Mar 31,
2012
Mar 31,
2013
Mar 31,
2014
Mar 31,
2015
Mar 31,
2016
Mar 31,
2017
Mar 31,
2018
Mar 31,
2019
Mar 31,
2020
Mar 31,
2021
Mar 31,
2022
Mar 31,
2023
Mar 31,
2024
Cash and deposits-50,88463,509--------23,83134,203
Notes receivable - trade-----------370472
Accounts receivable - trade-----------82,99865,429
Merchandise and finished goods-16,70316,223--------18,66219,471
Work in process-624390--------4869
Raw materials and supplies-3,6203,417--------5,2636,590
Other-4,0224,925--------14,22719,296
Allowance for doubtful accounts--1-3---------279-314
Current assets-132,582156,006150,672194,739157,011-----145,119145,215
Buildings, net-----------6,52414,602
Structures, net-----------5350
Machinery and equipment, net-----------2,1599,113
Vehicles, net-----------59
Tools, furniture and fixtures, net-----------1,0311,040
Land-8,2408,266--------6,7966,796
Leased assets, net-158155--------14769
Construction in progress-2,454816--------20,3203,966
Property, plant and equipment-27,42027,62829,10427,99128,550-----37,03535,644
Manufacturing and Marketing Approval-----------18,42212,682
Software-1,1501,826--------8,6868,638
Other-269102--------5,6005,194
Intangible assets-14,12316,585--------32,70826,513
Investment securities-18,17321,739--------20,09714,270
Stocks and investments in capital of subsidiaries and affiliates-----------38,45438,454
Deferred tax assets-5,0115,2152,9782,3452,396-----5,1875,704
Prepaid pension costs-----------2,4244,302
Other-2,8793,657--------1,8803,743
Allowance for doubtful accounts-------------1,997
Investments and other assets-25,51330,885--------68,04264,475
Non-current assets-76,21884,399153,528160,660165,767-----137,785126,633
Assets-206,760237,640304,200355,399322,778388,463391,186408,768405,285459,976421,179435,699
Electronically recorded obligations - operating-----------1,306-
Accounts payable - trade-----------20,05919,169
Short-term borrowings-----------7,0007,500
Current portion of long-term borrowings-----------1,907-
Accounts payable - other-9,8689,695--------23,06522,031
Income taxes payable-3,0388,169--------6,3253,353
Accrued consumption taxes-----------120-
Deposits received-----------1067,571
Provision for bonuses-3,0853,573--------2,0802,606
Other-1,6473,249--------571877
Current liabilities-28,11639,18656,34073,23053,434-----62,54163,108
Long-term borrowings-----------20,00020,000
Derivative liabilities-----------1629
Asset retirement obligations-160221--------311311
Other-1,0661,521--------775895
Non-current liabilities-10,78711,24436,08122,16115,460-----21,10221,235
Liabilities-38,90350,43092,42195,39168,894100,90598,614106,20895,639123,133127,883130,329
Share capital-7,0807,264--------8,7028,777
Legal capital surplus-----------9,3979,472
Capital surplus-7,7757,958--------9,3979,472
Legal retained earnings-----------1,5511,551
Reserve for retirement allowance-----------372372
General reserve-----------89,10989,109
Retained earnings brought forward-----------82,14873,576
Retained earnings-151,001162,727178,840221,945223,418249,225258,659273,422273,238290,477238,071240,029
Treasury shares--2-9---------364-1,018
Shareholders' equity-165,855175,328--------190,915181,839
Valuation difference on available-for-sale securities-1,9204,035--------8,0155,506
Deferred gains or losses on hedges-------------20
Valuation and translation adjustments--1,0475,481--------8,0155,485
Share acquisition rights-324399--------331181
Net assets164,861165,132181,209-------297,507199,261187,505
Liabilities and net assets-199,640231,105--------282,904271,848